Drug pricing in Canada just got more industry-friendly.
Canadian drug prices are already the fourth highest in the industrialized world. Now, with the release of new guidelines for the staff at the Patented Medicine Prices Review Board (PMPRB) at the end of June, the situation is poised to potentially get even worse.
The review board is the federal agency that was set up 1987 to ensure that the prices for patented drugs are not “excessive.”